{"entity":{"id":"iopromide","kind":"drug","name":"Iopromide","aka":["iopromide","Ultravist"],"tldr":"A CT dye given into a vein. In the United States it is also licensed for contrast-enhanced mammography, a breast X-ray taken after the dye to show cancers that ordinary mammograms can miss.","summary":"Bayer's Ultravist (NDA 020220, first approved 10 May 1995) is indicated for intra-arterial procedures, excretory urography, contrast CT of the head and body, and \"Contrast mammography in adults as an adjunct following mammography and/or ultrasound\". Its boxed warning reads \"NOT FOR INTRATHECAL USE\". ATC V08AB05.","status":"approved","asOf":"2026-11-04","links":[{"label":"Drugs@FDA Ultravist (NDA 020220)","url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020220"},{"label":"DailyMed label: Ultravist","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df917c3a-59a2-4ed1-8470-8a5394c73325"},{"label":"WHO ATC index V08AB: low osmolar X-ray contrast media","url":"https://atcddd.fhi.no/atc_ddd_index/?code=V08AB&showdescription=no"}],"tags":["contrast-agents-gaps-2026-11","diagnostic"],"related":[],"cancers":[],"sections":[],"technologies":["iodinated-contrast-media","ct","contrast-enhanced-mammography"],"targets":[],"drugs":[],"companies":["bayer"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo contrast agent gap fill (Drugs@FDA, FDA labels, DailyMed, EMA register, WHO ATC index)","editedOn":"2026-11-04"},"brand":"Ultravist","modality":"Iodinated contrast agent for CT, angiography and contrast-enhanced mammography (intravenous, intra-arterial)","mechanism":"A non-ionic low-osmolar iodinated molecule; enhancing tumours with leaky vessels take up more of it and appear bright on CT and on contrast mammography.","approvals":[{"region":"US","year":1995,"indication":"Angiography; excretory urography; contrast CT of the head and body; contrast mammography as an adjunct after mammography or ultrasound","note":"NDA 020220; Bayer"}],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/iopromide/","neighbours":{"technology":[{"id":"contrast-enhanced-mammography","kind":"technology","name":"Contrast-enhanced mammography","route":"/technologies/contrast-enhanced-mammography/"},{"id":"ct","kind":"technology","name":"CT (computed tomography)","route":"/technologies/ct/"},{"id":"iodinated-contrast-media","kind":"technology","name":"Iodinated and barium contrast for CT and X-ray","route":"/technologies/iodinated-contrast-media/"}],"company":[{"id":"bayer","kind":"company","name":"Bayer","route":"/companies/bayer/"}]}}